unknown
Stage
About
Cadenza Bio is a biotechnology company developing novel small-molecule oral drugs to treat demyelinating and inflammatory diseases by halting progression, promoting repair, and improving patient quality of life.
Explore Cadenza Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.